What is ImmunityBio, Inc.'s payments for finance leases?

ImmunityBio, Inc. (IBRX) reported payments for finance leases of $13K in Q1 2026.

What is the long-term trend for ImmunityBio, Inc.'s payments for finance leases?

Over 3 years (2022 to 2025), ImmunityBio, Inc.'s payments for finance leases has grown at a -21.6% compound annual growth rate (CAGR), from $58K to $28K.

What does payments for finance leases mean?

Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.

ImmunityBio, Inc. IBRX Payments for finance leases

Payments for finance leases at other companies

IncyteINCY

$1.18M+8.6%

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s payments for finance leases?: ImmunityBio, Inc. (IBRX) reported payments for finance leases of $13K in Q1 2026.
What is the long-term trend for ImmunityBio, Inc.'s payments for finance leases?: Over 3 years (2022 to 2025), ImmunityBio, Inc.'s payments for finance leases has grown at a -21.6% compound annual growth rate (CAGR), from $58K to $28K.
What does payments for finance leases mean?: Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.